Insmed plans to begin Arikace study this year
In addition, the company is also planning European registration Phase 3 clinical trial of Arikace in Cystic Fibrosis (CF) patients with Pseudomonas aeruginosa (Pa) lung infections. The randomized
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.